Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		81,850,000
Beginning balance at Dec. 31, 2024	$ 66,927	$ 8	$ 629,673	$ 52	$ (562,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	339,142	339,000
Issuance of common stock upon exercise of stock options	$ 1,049		1,049
Issuance of common stock upon release of stock awards (in shares)		696,000
Issuance of common stock under employee stock purchase plan (in shares)		151,000
Issuance of common stock under employee stock purchase plan	317		317
Issuance of common stock in connection with an equity offering, net of issuance costs (in shares)		7,245,000
Issuance of common stock in connection with an equity offering, net of issuance costs	16,442	$ 1	16,441
Stock-based compensation	7,424		7,424
Net loss	(53,575)				(53,575)
Other comprehensive income (loss)	(40)			(40)
Ending balance (in shares) at Sep. 30, 2025		90,281,000
Ending balance at Sep. 30, 2025	38,544	$ 9	654,904	12	(616,381)
Beginning balance (in shares) at Jun. 30, 2025		90,254,000
Beginning balance at Jun. 30, 2025	55,631	$ 9	652,391	(3)	(596,766)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of stock awards (in shares)		27,000
Stock-based compensation	2,513		2,513
Net loss	(19,615)				(19,615)
Other comprehensive income (loss)	15			15
Ending balance (in shares) at Sep. 30, 2025		90,281,000
Ending balance at Sep. 30, 2025	38,544	$ 9	654,904	12	(616,381)
Beginning balance (in shares) at Dec. 31, 2025		90,478,000
Beginning balance at Dec. 31, 2025	$ 50,529	$ 9	657,292	8	(606,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	0
Issuance of common stock upon release of stock awards (in shares)		945,000
Issuance of common stock under employee stock purchase plan (in shares)		97,000
Issuance of common stock under employee stock purchase plan	$ 148		148
Issuance of common stock in connection with an equity offering, net of issuance costs (in shares)	0	18,000,000
Issuance of common stock in connection with an equity offering, net of issuance costs	$ 24,902	$ 2	24,900
Stock-based compensation	4,559		4,559
Net loss	(28,837)				(28,837)
Other comprehensive income (loss)	(63)			(63)
Ending balance (in shares) at Sep. 30, 2026		109,520,000
Ending balance at Sep. 30, 2026	51,238	$ 11	686,899	(55)	(635,617)
Beginning balance (in shares) at Jun. 30, 2026		91,388,000
Beginning balance at Jun. 30, 2026	32,958	$ 9	660,451	(13)	(627,489)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of stock awards (in shares)		132,000
Issuance of common stock in connection with an equity offering, net of issuance costs (in shares)		18,000,000
Issuance of common stock in connection with an equity offering, net of issuance costs	24,902	$ 2	24,900
Stock-based compensation	1,548		1,548
Net loss	(8,128)				(8,128)
Other comprehensive income (loss)	(42)			(42)
Ending balance (in shares) at Sep. 30, 2026		109,520,000
Ending balance at Sep. 30, 2026	$ 51,238	$ 11	$ 686,899	$ (55)	$ (635,617)